Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
2-Benzofurancarboxylic acid, 3-(bromomethyl)-, ethyl ester REF: IN-DA002XCZCAS: 29115-34-2 | - - - | To inquire | Tue 10 Dec 24 | |
Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate REF: 3D-EBA11534CAS: 29115-34-2 | Min. 95% | To inquire | Tue 21 Jan 25 | |
MCC1019 REF: TM-T69496CAS: 29115-34-2 | - - - | 1,437.00 €~2,364.00 € | Mon 27 Jan 25 | |
Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate REF: 10-F642687CAS: 29115-34-2 | 97% | - - - | Discontinued product |
2-Benzofurancarboxylic acid, 3-(bromomethyl)-, ethyl ester
CAS:29115-34-2
Formula:
C12H11BrO3
Molecular weight:
283.1179
Ref: IN-DA002XCZ
Undefined size | To inquire |
Estimated delivery in United States, on Tuesday 10 Dec 2024
Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate
CAS:29115-34-2
Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate (BMC) is a potent anticancer agent that inhibits cancer cell growth by inhibiting …
Formula:
C12H11BrO3
Purity:
Min. 95%
Molecular weight:
283.12 g/mol
Ref: 3D-EBA11534
50mg | 213.00 € | ||
500mg | 850.00 € |
Estimated delivery in United States, on Tuesday 21 Jan 2025
MCC1019
CAS:29115-34-2
MCC1019 is a novel selective inhibitor of the Polo-box domain of Polo-like kinase 1 (PLK1).
Formula:
C12H11BrO3
Color and Shape:
Liquid
Molecular weight:
283.12
Ref: TM-T69496
25mg | 1,437.00 € | ||
50mg | 1,872.00 € | ||
100mg | 2,364.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
Ethyl 3-(bromomethyl)-1-benzofuran-2-carboxylate
CAS:29115-34-2
Purity:
97%
Molecular weight:
283.1210021972656
Ref: 10-F642687
1g | Discontinued | Request information | |
2.5g | Discontinued | Request information | |
50mg | Discontinued | Request information | |
100mg | Discontinued | Request information | |
250mg | Discontinued | Request information | |
500mg | Discontinued | Request information |